The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses.
about
Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterologySystematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn's diseaseMesenchymal stem cells and their therapeutic applications in inflammatory bowel disease.Human Gingiva-Derived Mesenchymal Stem Cells Inhibit Xeno-Graft-versus-Host Disease via CD39-CD73-Adenosine and IDO Signals.Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality.Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases.Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential.Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer.Mammalian MSC from selected species: Features and applications.Stem cell transplant in inflammatory bowel disease: a promising modality of treatment for a complicated disease course.Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases.Ethical and Safety Issues of Stem Cell-Based Therapy.Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.
P2860
Q28077427-76234E0B-A4B2-49AA-A11F-1F1F04124D3EQ33768359-094AE4CD-1972-4820-A286-6DD910BE8F1EQ33914228-A85F11B5-3EC3-4788-B8C8-425E434FE03FQ37619985-BE01666B-371A-443A-830D-52C47A91E75AQ38993061-A17CE335-89EE-42B8-B11F-41E31D57742DQ39017821-58A73E3C-91E4-499D-B3C0-B476244B5AD7Q39441667-42B4B806-FD39-4A9D-9539-A21D61BC458DQ41691710-44B1177C-A085-401A-95E6-4C606EDB2E9FQ46307085-59C11763-D8E2-455A-955E-0F3A3459411DQ47099140-92263DEA-91DB-4B2E-AF9D-66469BCEDE8CQ47287228-BEC1981E-6FC4-4208-9BF7-D66690B53031Q48234353-9AB85AF0-DCE8-4F3E-B3F6-1ABCBD76565BQ50050571-1453B1F5-85B8-463B-8C21-F44951081897Q55387791-11D16BC5-C2D1-484E-9325-A378769BE05D
P2860
The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
The safety of autologous and m ...... hase 1 trial with three doses.
@en
The safety of autologous and m ...... hase 1 trial with three doses.
@nl
type
label
The safety of autologous and m ...... hase 1 trial with three doses.
@en
The safety of autologous and m ...... hase 1 trial with three doses.
@nl
prefLabel
The safety of autologous and m ...... hase 1 trial with three doses.
@en
The safety of autologous and m ...... hase 1 trial with three doses.
@nl
P2093
P2860
P356
P1476
The safety of autologous and m ...... hase 1 trial with three doses.
@en
P2093
J Galipeau
K Y Chiang
R Chinnadurai
S Kugathasan
P2860
P304
P356
10.1111/APT.13717
P407
P577
2016-07-07T00:00:00Z